Recruiting

Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria

The goal of this interventional study is to learn from patients and healthcare providers at 4 health institutions (study sites) in Abuja and Kano in Nigeria what ways to best develop the content of a Hypertensive Disorders of Pregnancy ( HDP) Management package for pregnant women, and evaluate the effectiveness of implementing this package in improving cardiovascular health of pregnant women. The main question it aims to answer is: Will a contextualized home BP monitoring program lead to better BP control among…

ClinicalTrials.gov IDNCT06859359
PhaseNA
Enrollment1200
SponsorWashington University School of Medicine
AgeNo minimum reported
SexFEMALE
I'm interested View official listing

Conditions studied

Hypertensive Disorder of Pregnancy

About this study

The goal of this interventional study is to learn from patients and healthcare providers at 4 health institutions (study sites) in Abuja and Kano in Nigeria what ways to best develop the content of a Hypertensive Disorders of Pregnancy ( HDP) Management package for pregnant women, and evaluate the effectiveness of implementing this package in improving cardiovascular health of pregnant women. The main question it aims to answer is: Will a contextualized home BP monitoring program lead to better BP control among patients with HDP in Nigeria?

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Postpartum adults (\>18 years) * postpartum emancipated minors (in accordance with the Nigerian guidelines for young persons' participation in research and reproductive health services) * with diagnosis of HDP prior to delivery delivered at one of the participating sites able to provide informed consent. Exclusion Criteria: * unable to provide consent.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.